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S U M M A R Y
Objectives: To report that dengue fever (DF) could have triggered Plasmodium ovale wallikeri malaria.
Methods: A retrospective case report of P. ovale malaria and DF in a single patient in Rio de Janeiro, Brazil,
who had lived in Angola, is presented.
Results: On the second week of illness, the patient was referred to our research service. As symptoms had
persisted up to day 14, malaria was also considered, based on the patient’s long-standing
epidemiological history. On day 16 of illness, a thick blood smear was positive for P. ovale
(3480 parasites/mm3), PCR for malaria was positive for P. ovale wallikeri, and the kinetics of dengue
virus (DENV) antibodies suggested a recent primary dengue infection.
Conclusions: Concurrent infections of DENV and malaria have rarely been reported; the actual impact of
these sequential or simultaneous infections remains unknown. Therefore, DF must be considered as a
potential co-morbidity for malaria, because of its inﬂuence on ﬂuid electrolyte management. The case
presented showed consistent temporal, clinical, and laboratory evidence that the relapse or the long
incubation period of P. ovale malaria may have been triggered by a recent DF episode. To the authors’
knowledge, this is the ﬁrst report of DENV and P. ovale co-infection.
 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
Contents lists available at ScienceDirect
International Journal of Infectious Diseases
jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Concurrent infections of dengue virus (DENV) and Plasmodium
vivax or Plasmodium falciparum have rarely been reported. Thus,
despite a wide geographical overlap of the two diseases in endemic
areas, the actual impact of these sequential or co-infections is
unknown. In fact, there are only a few reports of the simultaneous
observation of dengue and malaria.1–5 To the authors’ knowledge,
this is the ﬁrst report of DENV and Plasmodium ovale co-infection.
The incidence of P. ovale malaria is low. Since its description in
1922, P. ovale malaria has typically remained restricted to tropical* Corresponding author. Tel.: +55 (21) 3865-9110.
E-mail address: otilia.lupi@ini.ﬁocruz.br (O. Lupi).
http://dx.doi.org/10.1016/j.ijid.2016.01.008
1201-9712/ 2016 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Africa and a few islands in Southeast Asia and the Middle East.6 The
real burden of P. ovale malaria is probably underestimated. Recent
studies using molecular techniques have reported a prevalence of
15% in rural zones of Nigeria and Papua New Guinea and of 9.3% in
children under 6 years of age in Equatorial Guinea.7 In a recent
Spanish report, P. ovale was diagnosed in approximately 7% of
imported malaria cases, representing the second most frequently
found species after P. falciparum, probably reﬂecting immigration
from West Africa.7,8 P. ovale malaria, usually clinically benign
compared with malaria arising from other common species, has
been well-studied because of its traditional use in the malaria
therapy of neurosyphilis.
The existence of two species (or subspecies) of P. ovale
occurring sympatrically in Asia and Africa – P. ovale curtisi and
P. ovale wallikeri – is correlated with different patterns of relapse.6ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
O. Lupi et al. / International Journal of Infectious Diseases 44 (2016) 20–24 21The prepatent period usually ranges from 12 to 20 days, with a
median of 14.4 days. There are descriptions of incubation periods
as long as 4 years, with maximum parasite counts registered
around the ninth day of disease. The restriction of P. ovale to young
erythrocytes could explain the low parasitemia usually found in
infections (approximately 6000 parasites/ml). Relapses of P. ovale
are less common than for P. vivax, with an estimated risk of 1:200,
and relapses can arise as early as 17 days or as late as 4 years after
effective therapy.6,8 In Brazil, a total of 39 cases of P. ovale malaria
have been recorded, showing a gradually increasing trend in recent
years as a result of the migration of travelers from P. ovale-endemic
regions.9,10 The low prevalence of this parasite, combined with its
morphological similarity to P. vivax and the low sensitivity of
currently available rapid diagnostic tests, could increase the rates
of P. ovale misdiagnosis.
Dengue is a mosquito-borne infection caused by four serotypes
of the dengue Flavivirus (DENV1–DENV4) and is the most common
arboviral disease worldwide.11 Since the 1980s, dengue has
become a major public health issue in Brazil, where all four
serotypes have been isolated. Seven percent of dengue cases
worldwide are reported from Brazil. In 2013, 921 716 dengue cases
were registered by the Brazilian health surveillance system.12,13
The incubation period ranges from 3 to 10 days, 30–50% of
infections are asymptomatic, and 10% of cases may have a poor
prognosis, with a 1–3% mortality rate even in the presence of ideal
assistance care services.14,15
Even in overlapping regions, little is known about the reciprocal
inﬂuence of malaria and dengue. A case of dengue in a patient from
the city of Rio de Janeiro, Brazil, 2 years after leaving Luanda,
Angola, is reported here. As there is no autochthonous P. ovale
malaria in the Americas, the authors raise the possibility that
dengue could have triggered a P. ovale malaria relapse or the
expression of a latent infection not yet manifested.
2. Methods
The study was performed at the Laborato´rio de Doenc¸as Febris
Agudas at the Instituto Nacional de Infectologia Evandro Chagas
(INI-FIOCRUZ), a regional dengue center that integrates the Center
for Malaria Research and Training (CPD-Mal) of FIOCRUZ, Rio de
Janeiro, Brazil. CPD-Mal covered 25% to 30% of attendant care of all
conﬁrmed malaria cases registered in the state of Rio de Janeiro
from 2005 to 2014 (unpublished data). During the period
December 2010 to June 2014, 24 patients were diagnosed with
dengue and malaria co-infection (unpublished data). All of these
patients had a history of recent travel to a malaria endemic area.Figure 1. Giemsa-stained thick and thin blood smears. (A) Plasmodium ovale trophozoi
slightly enlarged oval-shaped infected erythrocytes. (C) Plasmodium ovale gametocyte i
granules.The patients had never used chemoprophylaxis for malaria and all
had been immunized for yellow fever.
The diagnosis of malaria cases at CPD-Mal is usually made on
the basis of direct microscopic identiﬁcation of the hematozoa on
thick and thin blood smears stained with Giemsa, rapid diagnostic
tests (RDT), and a single conventional PCR for Plasmodium16 and P.
vivax17 and nested PCRs for P. falciparum18 and Plasmodium
malariae.19 In the case of P. ovale diagnosis, a ﬁrst reaction with the
genus-speciﬁc primer set rPLU1–rPLU5 is used, followed by the
second reaction using two pairs of primers: rOVA1–rOVA2 for P.
ovale curtisi ampliﬁcation19 and rOVA1v–rOVA2 v for P. ovale
wallikeri detection.20
At CPD-Mal, a dengue diagnosis is considered routinely in the
protocol for the investigation of fever, as well as in suspected cases
of malaria, and dengue is screened for in serum samples obtained
at admission. A dengue diagnosis is conﬁrmed by standard
serological tests, IgM-Panbio in paired samples, conventional
PCR, and NS1 antigen test (NS-1 Ag) within the ﬁrst 5 days of
symptom onset. In the case presented here, the IgG-CDC titled
assay was also performed to conﬁrm the recent dengue
infection,21–23 since the patient was referred to our service only
after day 14 of fever. The previous samples collected in the basic
health service units were not recovered, because during the
epidemic season, the storage period is limited to 1 week, with the
exception of samples from critical patients and those who have
died.
3. Case report
In April 2013, a 52-year-old man was referred to CPD-Mal,
FIOCRUZ, with a history of chills, fever, headache, arthralgia,
myalgia, choluria, discrete jaundice, anorexia, diffuse abdominal
pain, nausea, and one episode of vomiting. The illness had begun
16 days before, and the patient had already received medical care
at a basic health unit, where he had been monitored every 2 days in
accordance with the Brazilian protocol as a suspected dengue
patient. IgM ELISA conﬁrmed the infection on day 7 of disease, and
laboratory examinations revealed leukopenia and thrombocyto-
penia. The patient had no criteria for severe dengue disease during
the ﬁrst week. He received supportive treatment, but as his fever
persisted at day 14, his epidemiological history of travel was
reviewed. Malaria was considered, as well the possibility of
hepatitis, typhoid fever, and unusual forms of dengue, after
conﬁrmation of a long stay in Luanda, Angola.
The patient had high blood pressure and reported previous
episodes of P. falciparum malaria in 2009 and 2011 in Angola,
both treated successfully with only therapeutic schemes effectivetes (arrows) in thick smear. (B) Plasmodium ovale trophozoites in thin smear; see
n thin smear; note ﬁmbriated borders of red blood cells showing dark Schu¨ffner’s
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O. Lupi et al. / International Journal of Infectious Diseases 44 (2016) 20–2422for P. falciparum malaria, without the use of primaquine.
Epidemiologically important facts were his residence in Angola
between 2007 and 2011, with short visits to a non-endemic
malarial area in Brazil every 3 months. In December 2011, he
moved back to Brazil and did not return to Angola or visit another
malaria endemic area.
On admission to the outpatient service of FIOCRUZ on day 16 of
disease, the patient presented moderate anemia, fever, mild
jaundice, and dehydration, without signs of circulatory collapse.
There was no tachycardia, no respiratory distress, and no
coagulation disturbance. A thick blood smear was positive for P.
ovale and the parasitemia was 3480 parasites/mm3, with the
presence of gametocytes, schizonts, and trophozoites (Figure 1).
The PCR for malaria was positive for Plasmodium and negative for
P. vivax, P. falciparum, and P. malariae. An RDT was negative. In view
of these results, a blood sample was submitted to P. ovale PCR using
primers speciﬁcally designed for the diagnosis of P. ovale curtisi19
and P. ovale wallikeri20; P. ovale wallikeri was identiﬁed.
The patient had no glucose 6-phosphate enzyme deﬁciency. The
results of a complete blood count were as follows: hemoglobin
10.0 g/dl, hematocrit 32.4%, platelets 145 109/l , and white blood
cell count 8.98 109/l (with differential 0/0/0/1/15/53/21/10).
Other values included alkaline phosphatase of 130.0 U/l, gamma-
glutamyl transferase of 382.0 U/l, aspartate aminotransferase of
80.0 U/l, alanine aminotransferase of 36.0 U/l, C-reactive protein of
10.5 mg/dl, total bilirubin of 1.96 mg/dl, and creatinine of 1.67 mg/
dl. Table 1, shows a summary of the most relevant laboratory
results and clinical signs for the complete patient follow-up.
The serology for dengue panel was repeated on day 16, and the
serum was reactive for IgM and IgG. NS-1 Ag and dengue PCR
results were negative, as expected. This step was performed in
order to differentiate between sequential and simultaneous
infections. There was a signiﬁcant dengue IgG-CDC titer increase
(seroconversion), and dengue IgM-Panbio was still reactive on day
60 and negative on day 90 of follow-up, suggesting a recent
primary dengue infection, although a previous DENV infection
could not be ruled out completely (Table 1). Acute viral hepatitis
and typhoid fever were ruled out by serological tests and cultures.
Malaria treatment was initiated immediately using chloroquine
and primaquine (total cumulative dose 3.2 mg/kg), after which the
patient became apyretic. The parasitemia decreased rapidly and
became negative on day 3 of treatment. Follow-up was performed
weekly until day 90, and the patient was considered cured, with
complete clinical recovery after this period.
4. Discussion
This is the ﬁrst report of concurrent or sequential dengue and
ovale malaria. Considering that it would be difﬁcult to discriminate
a malaria relapse or a delayed incubation period from a new P.
ovale infection in endemic regions and that there is no transmis-
sion of this species in the Americas, it was considered that this case
deserved to be reported. Unfortunately, as a result of the lack of
initial samples, the demonstration of recent DF had to be
investigated with only the speciﬁc antibody kinetics. Nevertheless,
the proﬁle and chronology of the clinical presentation of the
disease clearly points to the temporal precedence of dengue in
relation to the P. ovale wallikeri malaria episode. This raises the
possibility that the dengue may have triggered the emergence of a
latent previous P. ovale infection or the relapse of a very old ovale
malaria. The intense inﬂammatory reaction, classically recognized
in symptomatic dengue and well-described in severe cases,24 could
have caused a stress response resulting in the re-emergence of
P. ovale in the circulation.
Because malaria is classically recognized to be a disease caused
by an agent endowed with important mitogenic and polyclonal
O. Lupi et al. / International Journal of Infectious Diseases 44 (2016) 20–24 23B-lymphocyte activation (PBA) properties,25,26 one could ask
whether the dengue serological evidence could not have arisen
from the marked malaria-associated PBA.27,28 However, some
evidence indicates that this was not the case in the present patient:
(1) clinically, there were two clear disease patterns; (2) false-
positive serological results related to the malaria-associated PBA
usually present low titers and decrease early after treatment,28
unlike the situation described here in which there were signiﬁcant
antibody dengue titers at up to day 90 of the disease; and (3)
although the anti-DENV IgM test was negative on day 90, the
speciﬁc IgG titers continued to rise after malaria treatment on day
16, despite parasite clearance (conﬁrmed by negative PCR on day
19) and it was still high on day 90.
The outcome of the concurrence of a non-severe dengue with P.
ovale malaria reported here was positive, possibly as a result of a
co-infection of the DENV with a relatively benign Plasmodium.
However, this outcome should not always be expected, as both
diseases may present severe forms and co-infection could enhance
their respective morbidities. This has already been reported in
DENV and P. falciparum and in DENV and P. vivax co-infections.5,29–
38
Some authors have recently reported that usually benign forms
of P. vivax malaria are becoming more severe in some regions of
South America and Asia. Because dengue and malaria overlap in
some of these regions,29,37–39 the data presented here emphasize
the need for the accurate recognition of dengue as a co-morbidity
of malaria to avoid the false diagnosis of severe disease caused by a
relatively benign Plasmodium such as P. vivax.
The clinical case presented here showed temporal, clinical, and
laboratory evidence consistent with a relapse or a long incubation
period of a P. ovale wallikeri malaria being triggered by a dengue
episode. Clinicians must therefore keep this possibility in mind
when facing cases with a clinical evolution similar to that
described here. The results also highlight the importance of
adequate training for malaria diagnosis, allowing the detection of
imported cases caused by species of Plasmodium that are not
prevalent in the country, such as P. ovale in Brazil.
Finally, this is the ﬁrst description of P. ovale wallikeri in Angola.
Further studies should be done using P. ovale-speciﬁc PCR to assess
the prevalence of P. ovale curtisi and P. ovale wallikeri in endemic
areas of Angola.
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